GlassScriptPhysician profile
Monique E Schneider
NPI 1023554003
$2,913.79
in general payments reported to CMS, 2019-2025
24 companies · $680 in 2025
The $680 reported for 2025 was more than what 91% of Obstetrics & Gynecology (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $388 · 2022: $704 · 2023: $756 · 2024: $385 · 2025: $680.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,757 · Education: $64.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,756.72 |
| Education | $64.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $506.63 | 2021-2025 | Veozah |
| Abbvie INC. | $445.83 | 2021-2025 | |
| Mayne Pharma Commercial LLC | $346.54 | 2022-2025 | |
| Exeltis, USA INC. | $282.02 | 2021-2025 | Slynd |
| Sumitomo Pharma America, INC. | $229.71 | 2023-2025 | Myfembree |
| Evofem Biosciences, INC. | $184.98 | 2021-2025 | Phexxi, Solosec, Phexx |
| Pfizer INC. | $136.81 | 2022-2024 | |
| Daiichi Sankyo INC. | $99.80 | 2021-2023 | Injectafer |
| Hologic Sales and Service, LLC | $87.90 | 2022-2025 | Aptima, Acessa Provu System |
| Organon LLC | $81.34 | 2022-2025 | Nexplanon |
| Agile Therapeutics, INC. | $71.27 | 2021-2022 | |
| Millicent US INC | $69.53 | 2024-2025 | Intrarosa, Femlyv, Femring |
| Therapeuticsmd, INC. | $59.10 | 2021-2022 | |
| Coopersurgical, INC. | $53.38 | 2021-2025 | Paragard T 380a |
| Sage Therapeutics, LLC | $50.08 | 2025 | Zurzuvae |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $45.84 | 2021-2025 | |
| Baxter Healthcare | $37.65 | 2023 | Perclot |
| Myovant Sciences INC. | $28.43 | 2022 | |
| Roche Diagnostics Corporation | $19.36 | 2021 | |
| Exact Sciences Corporation | $18.66 | 2025 | Cologuard Collection Kit |
| Amgen INC. | $18.13 | 2025 | Evenity |
| Supernus Pharmaceuticals, INC. | $15.36 | 2025 | Qelbree |
| Heron Therapeutics, INC. | $13.56 | 2022 | |
| Merck Sharp & Dohme LLC | $11.88 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Monique Schneider listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.